In contrast, it is unclear what the best approach is with asymptomatic patients carrying a deleterious variant in LIG4. In theory, they will accumulate DNA double-strand breaks and cell damage that result in increased apoptosis of hematopoietic cells, with the consequent risk of late-onset aplastic anemia and malignancy. The gene discussed is LIG4; the disease is aplastic anemia.